Why the study?
Do serological markers of collagen turnover improve the diagnostic accuracy of HF-PEF and DD compared to BNP in treated hypertensive patients?
Observational (n=85)
Do serological markers of collagen turnover improve the diagnostic accuracy of HF-PEF and DD compared to BNP in treated hypertensive patients?
Markers of collagen turnover, particularly MMP-2, may offer improved diagnostic accuracy over BNP for identifying HF-PEF in hypertensive patients.
Answers are grounded in this paper and cite their sources.
May aid HF-PEF diagnosis in hypertensives; hypothesis-generating versus BNP, needing prospective validation.
AIMS: Heart failure with preserved ejection fraction (HF-PEF) can be difficult to diagnose in clinical practice. Myocardial fibrosis is a major determinant of diastolic dysfunction (DD), potentially contributing to the progression of HF-PEF. The aim of this study was to analyse whether serological markers of collagen turnover may predict HF-PEF and DD. METHODS AND RESULTS: We included 85 Caucasian treated hypertensive patients (DD n=65; both DD and HF-PEF n=32). Serum carboxy (PICP), amino (PINP), and carboxytelo (CITP) peptides of procollagen type I, amino (PIIINP) peptide of procollagen type III, matrix metalloproteinases (MMP-1, MMP-2, and MMP-9), and tissue inhibitor of MMP levels were assayed. Using receiver operating characteristic curve analysis, MMP-2 (AUC=0.91; 95% CI: 0.84, 0.98), CITP (0.83; 0.72, 0.92), PICP (0.82; 0.72, 0.92), B-type natriuretic peptide (BNP) (0.82; 0.73, 0.91), MMP-9 (0.79; 0.68, 0.89), and PIIINP (0.78; 0.66, 0.89) levels were significant predictors of HF-PEF (P<0.01 for all). Carboxytelo peptides of procollagen type I (AUC=0.74; 95% CI: 0.62, 0.86), MMP-2 (0.73; 0.62, 0.84), PIIINP (0.73; 0.60, 0.85), BNP (0.69; 0.55, 0.83) and PICP (0.66; 0.54, 0.78) levels were significant predictors of DD (P<0.05 for all). A cutoff of 1585 ng/mL for MMP-2 provided 91% sensitivity and 76% specificity for predicting HF-PEF and combinations of biomarkers could be used to adjust either sensitivity or specificity. CONCLUSION: Markers of collagen turnover identify patients with HF-PEF and DD. Matrix metalloproteinase 2 may be more useful than BNP in the identification of HF-PEF. This suggests that these new biochemical tools may assist in identifying patients with these diagnostically challenging conditions.
No takes yet. Share an insight, caveat, or question.
Martos et al. (2009) conducted an observational in Heart failure with preserved ejection fraction (HF-PEF) and diastolic dysfunction (n=85). Serological markers of collagen turnover (MMP-2) vs. B-type natriuretic peptide (BNP) was evaluated on Prediction of HF-PEF (AUC 0.91, 95% CI 0.84-0.98, p=<0.01).
Synapse has enriched 10 related papers. Consider them for comparative context: